Evoq Remedies Balance Sheet Annual

BSE: 543500 | NSE: - | ISIN: INE0JVD01011 | Sector: Biotechnology & Drugs

4.76 -0.09 (-1.86%)Updated : 11 Jul 2025

Interim Data

Annual Data

Fiscal Period	2025	2024	2023	2022
Period End Date	Mar 25	Mar 24	Mar 23	Mar 22
Total Liabilities Shareholders' Equity	50.01	36.86	34.90	33.33
Cash Equivalents	0.21	0.12	0.15	3.09
Other Liabilities Total	0.00	-	-	-
Long Term Debt	0.00	0.00	0.00	0.00
Common Stock Total	24.90	13.61	13.60	13.60
Other Equity Total	0.00	-0.01	-	-
Other Current Assets Total	10.83	0.32	7.62	0.32
Total Assets	50.01	36.86	34.90	33.33
Total Equity	44.54	25.24	24.79	23.17
Retained Earnings( Accumulated Deficit)	19.64	11.64	11.19	9.57
Total Common Shares Outstanding	2.49	1.36	1.36	1.36
Tangible Book Valueper Share Common Eq	17.89	18.56	18.22	17.03
Total Liabilities	5.47	11.62	10.11	10.17
Total Debt	0.00	4.24	9.58	8.16
Cashand Short Term Investments	0.21	0.12	0.15	3.09
Total Receivables Net	36.53	33.28	25.08	29.13
Notes Payable/ Short Term Debt	0.00	4.24	9.58	0.00
Deferred Income Tax	0.00	0.00	0.00	-
Accounts Receivable- Trade Net	8.62	1.74	17.22	25.40
Property/ Plant/ Equipment Total- Net	0.22	0.01	0.01	0.00
Total Current Liabilities	5.47	11.62	10.11	10.17
Total Inventory	2.22	3.13	2.03	0.78
Accounts Payable	3.50	3.28	-0.54	1.21
Other Currentliabilities Total	1.98	4.10	1.07	0.80
Total Long Term Debt	0.00	0.00	0.00	0.00
Other Long Term Assets Total	0.00	0.00	0.00	0.00
Note Receivable- Long Term	0.00	0.00	0.00	0.00
Total Current Assets	49.79	36.85	34.89	33.33
period Length	0.00	0.00	0.00	0.00
Current Portof LT Debt/ Capital Leases	-	-	-	8.16